Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.6800
+0.0300 (4.62%)
At close: Aug 6, 2026
Genetic Analysis AS Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21.55 | 21.17 | 20.68 | 23.16 | 20.75 | 13.38 | |
Revenue Growth | 8.13% | 2.36% | -10.71% | 11.65% | 55.08% | 72.54% |
Cost of Revenue | 5.34 | 4.7 | 3.11 | 4.43 | 3.91 | 1.28 |
Gross Profit | 3.36 | 16.47 | 17.57 | 18.73 | 16.84 | 12.1 |
Selling, General & Admin | 15.44 | 16.06 | 19.27 | 23.56 | 25.2 | 22.84 |
Depreciation & Amortization Expenses | 5.07 | 5.17 | 5.24 | 5.58 | 4.83 | 4.53 |
Other Operating Expenses | 6.15 | 5.94 | 7.28 | 13.43 | 14.99 | 13.6 |
Total Operating Expenses | 26.66 | 27.17 | 31.79 | 42.57 | 45.02 | 40.97 |
Operating Income | -23.31 | -10.7 | -14.22 | -23.84 | -28.18 | -28.87 |
Interest Income | 1.06 | 0.35 | 0.42 | 0.63 | 0.05 | - |
Interest Expense | -1.25 | -0.5 | -0.36 | -0.51 | -0.24 | -0.27 |
Other Non-Operating Income (Expense) | - | - | - | -0.09 | - | - |
Total Non-Operating Income (Expense) | -0.2 | -0.15 | 0.06 | 0.04 | -0.18 | -0.27 |
Pretax Income | -11.43 | -11.41 | -14.77 | -23.82 | -28.27 | -29.01 |
Net Income | -11.43 | -11.41 | -14.77 | -23.82 | -28.27 | -29.01 |
Net Income to Common | -11.43 | -11.41 | -14.77 | -23.82 | -28.27 | -29.01 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 67 | 69 | 49 | 38 | 25 | 25 |
Shares Outstanding (Diluted) | 67 | 69 | 49 | 38 | 25 | 25 |
Shares Change | 43.86% | 39.90% | 29.28% | 52.67% | 0.07% | 45.72% |
EPS (Basic) | -0.17 | -0.18 | -0.33 | -0.91 | -1.13 | -1.16 |
EPS (Diluted) | -0.17 | -0.18 | -0.33 | -0.91 | -1.13 | -1.16 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -1.4 | 2.05 | -12.08 | -17.38 | -19.69 | -27.7 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.02 | 0.03 | -0.24 | -0.45 | -0.79 | -1.11 |
Gross Margin | 15.58% | 77.80% | 84.95% | 80.87% | 81.17% | 90.42% |
Operating Margin | -108.16% | -50.51% | -68.72% | -102.91% | -135.84% | -215.80% |
Profit Margin | -53.05% | -53.91% | -71.40% | -102.82% | -136.28% | -216.80% |
FCF Margin | -6.52% | 9.68% | -58.41% | -75.02% | -94.88% | -207.07% |
EBITDA | -18.23 | -5.52 | -8.97 | -18.26 | -23.35 | -24.34 |
EBITDA Margin | -84.62% | -26.08% | -43.38% | -78.82% | -112.55% | -181.93% |
EBIT | -23.31 | -10.7 | -14.22 | -23.84 | -28.18 | -28.87 |
EBIT Margin | -108.16% | -50.51% | -68.72% | -102.91% | -135.84% | -215.80% |